The surge in United States Pharmaceutical CDMO Market Demand can be attributed to multiple factors reshaping the pharmaceutical landscape. According to , the market is projected to experience significant growth, reaching an anticipated value of 51.54 billion USD by 2035. This growth trajectory is characterized by a compound annual growth rate (CAGR) of 6.86%. The increasing emphasis on generic...